An adapted LC-MS/MS method for the determination of free plasma concentration of cefoperazone in children:

Min Kan1, Yue-E Wu1, Xue Li1

  • 1Department of Clinical Pharmacy, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, China.

Insights

Determining free cefoperazone levels in children is crucial for effective treatment. This study developed a validated LC-MS/MS method using minimal plasma, revealing significant individual variability in unbound drug concentrations.

Area of Science:

  • Pharmacokinetics
  • Analytical Chemistry
  • Pediatric Pharmacology

Background:

  • Cefoperazone's antimicrobial activity relies on its unbound concentration.
  • Limited protein binding data in children hinders optimal pediatric therapy.
  • Lack of validated methods for free cefoperazone in small pediatric samples.

Purpose of the Study:

  • Develop and validate an LC-MS/MS method for free cefoperazone determination in pediatric plasma.
  • Address the challenge of limited sample volumes in pediatric pharmacokinetic studies.
  • Provide a tool for optimizing cefoperazone dosing in children.

Main Methods:

  • Developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method.
  • Utilized ultrafiltration with only 70 μL of plasma.
  • Employed a C18 column and gradient elution with acetonitrile/water mobile phase.
  • Detected cefoperazone and ceftiofur (internal standard) using negative electrospray ionization.

Main Results:

  • Achieved excellent linearity (5-5000 ng/mL) and high accuracy (91.5-105.0%).
  • Demonstrated excellent precision (CV < 9.0%), low matrix effect (< 11.7%), and high recovery (92.9-95.9%).
  • Successfully applied the method to pediatric patients, showing significant individual variability in unbound cefoperazone (8.1-48.0%).

Conclusions:

  • The validated LC-MS/MS method is suitable for determining free cefoperazone in pediatric plasma.
  • Age and albumin levels significantly influence cefoperazone protein binding in children.
  • This method facilitates personalized antimicrobial therapy optimization in pediatric patients.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.1K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
150
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
134
Drug Concentrations: Measurements01:23

Drug Concentrations: Measurements

Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
938
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations01:15

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...
169